Compounds > 4-diphenylacetoxy-1,1-dimethylpiperidinium
Page last updated: 2024-10-21

4-diphenylacetoxy-1,1-dimethylpiperidinium and Drug Withdrawal Symptoms

4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Drug Withdrawal Symptoms in 2 studies

4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holland, LN1
Shuster, LC1
Buccafusco, JJ2

Other Studies

2 other studies available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Drug Withdrawal Symptoms

ArticleYear
Role of spinal and supraspinal muscarinic receptors in the expression of morphine withdrawal symptoms in the rat.
    Neuropharmacology, 1993, Volume: 32, Issue:12

    Topics: Animals; Blood Pressure; Cerebral Ventricles; Heart Rate; Injections, Intraventricular; Injections,

1993
Inhibition of the morphine withdrawal syndrome by a novel muscarinic antagonist (4-DAMP).
    Life sciences, 1991, Volume: 48, Issue:8

    Topics: Animals; Hemodynamics; Morphine; Muscarinic Antagonists; Naloxone; Parasympatholytics; Piperidines;

1991